March 23, 2020 - COVID-19 Response and the PrecISE Research Study
Update: July 16, 2020
Safety is our number one priority, for patients, their families, and our team members who work on all aspects of PrecISE. In response to the coronavirus (COVID-19), we paused recruitment on March 9, 2020. Each site is following policies and recommendations from institutional and local health and safety experts. As a network, we continue to work together, in conjunction with the National Heart, Lung, and Blood Institute (NHLBI) to assess this situation and optimize participant and personnel health and safety. Participant recruitment has opened at the following study sites:
California: University of California - San Francisco (not yet recruiting adolescents), and University of California - Davis
Colorado: National Jewish
Indiana: Riley Hospital for Children
Kansas: University of Kansas
Massachusetts: Boston Children's, and Brigham and Women’s Hospital
North Carolina: Wake Forest University
Ohio: Cleveland Clinic Main, and University Hospitals - Rainbow Babies and Children's Hospital
Pennsylvania: University of Pittsburgh
Wisconsin: University of Wisconsin-Madison
Please continue to check this page for updates.
What Can I Learn About Coronavirus (COVID-19)?
For information about COVID-19, please visit these resources from the Centers for Disease Control and Prevention (CDC) and the National Institutes of Health (NIH).
CDC: "Coronavirus (COVID-19) - What You Need to Know" https://www.cdc.gov/coronavirus/2019-nCoV/index.html
CDC: "People with Asthma and COVID-19" https://www.cdc.gov/coronavirus/2019-ncov/specific-groups/asthma.html
- NIH: "Coronavirus (COVID-19) Resources and News" https://www.nih.gov/health-information/coronavirus
The PrecISE Network and COVID-19
Dr. Michael Peters, a co-investigator for PrecISE, traveled from San Francisco, California to New York City to help with the emergency medical response to COVID-19. Read more in the article, "PrecISE Co-Investigator Honored as 'Hero Doc' by New York Post."